This peptide is primarily studied for its potential therapeutic applications, particularly in the field of cardiovascular and renal health. It has been investigated for its role in inhibiting fibrosis, especially in the heart and kidneys, making it a candidate for treating conditions like chronic kidney disease and heart failure. Additionally, it shows promise in reducing inflammation and preventing tissue scarring, which could be beneficial in post-surgical recovery or injury management. Research also suggests its potential in modulating blood pressure and improving vascular function, offering avenues for addressing hypertension-related complications. Its applications are still largely in the experimental and clinical trial stages, but it holds significant promise in regenerative medicine and chronic disease management.